Addressing Clinical Challenges in T-Cell Lymphomas Through Biomarker-Driven Therapy

Download All
Gain expert insights into best practices and emerging strategies in therapy for patients with T-cell lymphomas with this dynamic online educational program based on a live webinar. Download slides with all the key data, watch the on-demand webcast, listen to the podcast, and join the conversation around an expert-authored commentary.
Steven M. Horwitz, MD
Program Director
Francine Foss, MD
Steven M. Horwitz, MD
Talha Khan, PharmD, BCOP
Barbara Pro, MD

On-Demand Webcast

Watch this on-demand webcast from a satellite symposia at the 2021 Hematology meeting to learn from the experts how to use biomarkers in the diagnosis and selection of therapy for TCL, including future directions and key ongoing trials.

Steven M. Horwitz, MD
Program Director
Francine Foss, MD Barbara Pro, MD
Physicians: maximum of 2.5 AMA PRA Category 1 Credits Released: January 27, 2022 Expired: January 26, 2023

ClinicalThought

Read this commentary from lymphoma expert Steven M. Horwitz, MD, on the current approach for characterization and management of T-cell lymphomas using biomarkers and targeted therapies.

Steven M. Horwitz, MD Released: October 14, 2021

Downloadable Slidesets

Download this short summary slideset of key takeaway points from a CCO live symposium on biomarker-driven therapies for T-cell lymphomas.

Francine Foss, MD Steven M. Horwitz, MD Barbara Pro, MD Released: December 28, 2021

Download these slides from an ASH satellite symposium to learn how to optimally manage PTCL and ALCL subtypes of lymphoma using biomarkers and targeted therapy.

Barbara Pro, MD Released: December 9, 2021

Download these slides from an ASH satellite symposium to learn how to improve outcomes for relapsed/refractory PTCL using biomarkers and targeted therapy.

Steven M. Horwitz, MD Released: December 9, 2021

Download these slides from an ASH satellite symposium to learn about systemic treatments for cutaneous T-cell lymphomas using biomarkers and targeted therapy.

Francine Foss, MD Released: December 9, 2021

Podcast

In this podcast episode, listen to Steven M. Horwitz, MD; Francine Foss, MD; and Barbara Pro, MD, answer questions from an audience of healthcare professionals on managing patients with T-cell lymphoma using biomarker-driven therapies.

Francine Foss, MD Steven M. Horwitz, MD Barbara Pro, MD Released: January 31, 2022

Download this short summary of key points from a FAQ podcast on managing patients with T-cell lymphomas using biomarker-driven therapies and the latest clinical evidence.

Francine Foss, MD Steven M. Horwitz, MD Barbara Pro, MD Released: January 31, 2022

Summary Resource

Download this PDF guide to best practices for optimal team management of patients with T-cell lymphomas with biomarker-driven therapies.

Talha Khan, PharmD, BCOP Released: December 6, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Daiichi Sankyo, Inc.
Kyowa Kirin, Inc.
Seagen Inc.
Takeda Oncology

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings